rs587777409
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP3_ModeratePP5_Moderate
The NM_021008.4(DEAF1):c.762A>C(p.Arg254Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R254T) has been classified as Likely pathogenic.
Frequency
Consequence
NM_021008.4 missense
Scores
Clinical Significance
Conservation
Publications
- intellectual disability, autosomal dominant 24Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- intellectual disability-epilepsy-extrapyramidal syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- complex neurodevelopmental disorderInheritance: SD Classification: STRONG Submitted by: Illumina
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
DEAF1-related disorder Pathogenic:1Other:1
Variant classified as Pathogenic and reported on 10-24-2019 by GeneDx. Assertions are reported exactly as they appear on the patient provided laboratory report. GenomeConnect does not attempt to reinterpret the variant. The IDDRC-CTSA National Brain Gene Registry (BGR) is a study funded by the U.S. National Center for Advancing Translational Sciences (NCATS) and includes 13 Intellectual and Developmental Disability Research Center (IDDRC) institutions. The study is led by Principal Investigator Dr. Philip Payne from Washington University. The BGR is a data commons of gene variants paired with subject clinical information. This database helps scientists learn more about genetic changes and their impact on the brain and behavior. Participation in the Brain Gene Registry requires participation in GenomeConnect. More information about the Brain Gene Registry can be found on the study website - https://braingeneregistry.wustl.edu/. -
The DEAF1 c.762A>C variant is predicted to result in the amino acid substitution p.Arg254Ser. This variant was reported as de novo in multiple individuals with intellectual disability with neurodevelopmental disorder (Vulto-van Silfhout et al. 2014. PubMed ID: 24726472; Xiong et al. 2019. PubMed ID: 31031587; Chen et al. 2021. PubMed ID: 33705764; Table S1, McGee et al. 2023. PubMed ID: 35981081). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted as pathogenic. -
not provided Pathogenic:1
In vitro studies demonstrated that the R254S variant reduced DNA binding ability of the DEAF1 protein, however, R254S continued to activate Eif4g3 reporter expression (Vulto-van Silfhout et al., 2014); Not observed in large population cohorts (gnomAD); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 29366832, 31031587, 33705764, 24726472) -
Intellectual disability, autosomal dominant 24 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at